9373 A 0 0.1 the
9373 A 1 0.1 patient
9373 A 2 0.1 was
9373 A 3 0.1 treated
9373 A 4 0.1 as
9373 A 5 0.1 part
9373 A 6 0.1 of
9373 A 7 0.1 a
9373 A 8 0.1 clinical
9373 A 9 0.1 trial
9373 A 10 0.1 to
9373 A 11 0.1 test
9373 A 12 0.1 the
9373 A 13 0.1 effects
9373 A 14 0.1 of
9373 A 15 0.1 a
9373 A 16 0.1 new
9373 A 17 0.1 drugs
9373 A 18 0.1 combination
9373 A 19 0.1 on
9373 A 20 0.1 patients
9373 A 21 0.1 with
9373 A 22 0.1 advanced
9373 A 23 0.1 melanoma
9373 A 24 0.1 ,
9373 A 25 0.1 pictured
9373 A 26 0.1 .
9373 A 27 0.1 the
9373 A 28 0.1 study
9373 A 29 0.1 found
9373 A 30 0.1 61
9373 A 31 0.1 per
9373 A 32 0.1 cent
9373 A 33 0.1 of
9373 A 34 0.1 those
9373 A 35 0.1 treated
9373 A 36 0.1 with
9373 A 37 0.1 ipilimumab
9373 A 38 0.1 and
9373 A 39 0.1 nivolumab
9373 A 40 0.1 showed
9373 A 41 0.1 signs
9373 A 42 0.1 of
9373 A 43 0.1 their
9373 A 44 0.1 tumours
9373 A 45 0.1 shrinking
9373 A 46 0.1 .
9373 A 47 0.1 scientists
9373 A 48 0.1 at
9373 A 49 0.1 the
9373 A 50 0.1 hospital
9373 A 51 0.1 have
9373 A 52 0.1 conducted
9373 A 53 0.1 a
9373 A 54 0.1 trial
9373 A 55 0.1 ,
9373 A 56 0.1 treating
9373 A 57 0.1 patients
9373 A 58 0.1 diagnosed
9373 A 59 0.1 with
9373 A 60 0.1 advanced
9373 A 61 0.1 melanoma
9373 A 62 0.1 with
9373 A 63 0.1 a
9373 A 64 0.1 new
9373 A 65 0.1 type
9373 A 66 0.1 of
9373 A 67 0.1 treatment
9373 A 68 0.1 .
9373 A 69 0.1 the
9373 A 70 0.1 49
9373 A 71 0.1 year
9373 A 72 0.1 old
9373 A 73 0.1 woman
9373 A 74 0.1 showed
9373 A 75 0.1 a
9373 A 76 0.1 staggering
9373 A 77 0.1 response
9373 A 78 0.1 to
9373 A 79 0.1 a
9373 A 80 0.1 new
9373 A 81 0.1 combination
9373 A 82 0.1 of
9373 A 83 0.1 two
9373 A 84 0.1 drugs
9373 A 85 0.1 ,
9373 A 86 0.1 to
9373 A 87 0.1 treat
9373 A 88 0.1 skin
9373 A 89 0.1 cancer
9373 A 90 0.1 .
